Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Iron Infusion and Induced Hypophosphatemia: The Role of Fibroblast Growth Factor-23.
Coppolino G, Nicotera R, Cernaro V, Calimeri S, Leonardi G, Cosentino S, Comi A, Donato C, Lucia CM, Provenzano M, Michael A, Andreucci M. Coppolino G, et al. Among authors: comi a. Ther Apher Dial. 2020 Jun;24(3):258-264. doi: 10.1111/1744-9987.13435. Epub 2019 Oct 25. Ther Apher Dial. 2020. PMID: 31483921 Review.
An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD).
Simeoni M, Citraro ML, Cerantonio A, Deodato F, Provenzano M, Cianfrone P, Capria M, Corrado S, Libri E, Comi A, Pujia A, Abenavoli L, Andreucci M, Cocchi M, Montalcini T, Fuiano G. Simeoni M, et al. Among authors: comi a. Eur J Nutr. 2019 Aug;58(5):2145-2156. doi: 10.1007/s00394-018-1785-z. Epub 2018 Aug 3. Eur J Nutr. 2019. PMID: 30076458 Free PMC article. Clinical Trial.
Correction to: An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD).
Simeoni M, Citraro ML, Cerantonio A, Deodato F, Provenzano M, Cianfrone P, Capria M, Corrado S, Libri E, Comi A, Pujia A, Abenavoli L, Andreucci M, Cocchi M, Montalcini T, Fuiano G. Simeoni M, et al. Among authors: comi a. Eur J Nutr. 2019 Aug;58(5):2157. doi: 10.1007/s00394-018-1831-x. Eur J Nutr. 2019. PMID: 30302543 Free PMC article.
Atherosclerotic-nephropathy: an updated narrative review.
Simeoni M, Borrelli S, Garofalo C, Fuiano G, Esposito C, Comi A, Provenzano M. Simeoni M, et al. Among authors: comi a. J Nephrol. 2021 Feb;34(1):125-136. doi: 10.1007/s40620-020-00733-0. Epub 2020 Apr 8. J Nephrol. 2021. PMID: 32270411 Review.
Altered circulating marinobufagenin levels and recurrent intradialytic hypotensive episodes in chronic hemodialysis patients: a pilot, prospective study.
Bolignano D, Greco M, Presta P, Crugliano G, Sabatino J, Carullo N, Arena R, Leo I, Comi A, Andreucci M, Dragone F, Strangio A, Indolfi C, Foti DP, De Rosa S, Coppolino G. Bolignano D, et al. Among authors: comi a. Rev Cardiovasc Med. 2021 Dec 22;22(4):1577-1587. doi: 10.31083/j.rcm2204163. Rev Cardiovasc Med. 2021. PMID: 34957798 Free article.
Marinobufagenin, left ventricular geometry and cardiac dysfunction in end-stage kidney disease patients.
Bolignano D, De Rosa S, Greco M, Presta P, Patella G, Crugliano G, Sabatino J, Strangio A, Romano LR, Comi A, Cianfrone P, Andreucci M, Dragone F, Indolfi C, Foti DP, Coppolino G. Bolignano D, et al. Among authors: comi a. Int Urol Nephrol. 2022 Oct;54(10):2581-2589. doi: 10.1007/s11255-022-03161-0. Epub 2022 Mar 10. Int Urol Nephrol. 2022. PMID: 35274285
132 results